STOCK TITAN

Bio Green Med Solution (NASDAQ: BGMS) narrows Q2 loss as fire safety revenue grows

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bio Green Med Solution, Inc. reported second quarter results for the three months ended June 30, 2026, reflecting its transition into fire safety protection and distribution following the September 2025 acquisition of Fitters Sdn. Bhd. Product revenue from fire safety equipment was $336,000, generating a gross margin of approximately 23%.

Net loss was $0.4 million, improving from $1.3 million in the same period of 2025, driven largely by a sharp reduction in general and administrative expenses to $0.5 million from $1.2 million. There was no activity from discontinued biopharmaceutical operations in the current period.

Cash and cash equivalents totaled $3.8 million as of June 30, 2026, compared with $3.5 million at December 31, 2025, and the company estimates its current cash resources will fund planned expenditure into the first quarter of 2027. Total assets were $7.9 million and stockholders’ equity was $7.2 million, with liabilities remaining relatively low.

Positive

  • Net loss narrowed to $405,000 from $1,318,000 year-over-year, reflecting improved cost structure and the contribution of the new fire safety business.
  • General and administrative expenses fell to $497,000 from $1,249,000, indicating materially lower overhead under current management.
  • Cash and cash equivalents increased to $3.8 million and are estimated to fund planned expenditure into the first quarter of 2027.

Negative

  • The company remains loss-making, with a Q2 2026 net loss of $405,000 and limited cash runway only into the first quarter of 2027.
  • Revenues are still modest at $336,000 for the quarter, as the fire safety distribution business is at an early scale relative to expenses.

Insights

Analyzing...

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Product revenue - fire safety $336,000 Three months ended June 30, 2026
Gross margin on fire safety revenue 23% Three months ended June 30, 2026
Net loss $405,000 Three months ended June 30, 2026, vs $1,318,000 in 2025
General and administrative expenses $497,000 Three months ended June 30, 2026 (down from $1,249,000)
Cash and cash equivalents $3.8 million As of June 30, 2026
Total assets $7,854,000 As of June 30, 2026
Stockholders’ equity $7,160,000 As of June 30, 2026
Weighted average common shares outstanding 5,598,701 Three months ended June 30, 2026
discontinued operations financial
"Net loss from discontinued operations was $68,000 for the three months ended June 30, 2025"
Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.
general and administrative expenses financial
"General and administrative expenses decreased by approximately $0.7 million from $1.2 million"
Costs a company pays to run its basic operations that are not directly tied to making a product or delivering a service, such as executive salaries, office rent, utilities, accounting, legal and human resources. Investors care because these steady overhead costs reduce profits and cash flow regardless of sales volume, so changes in them reveal how efficiently management runs the business—like household bills that shrink or grow independently of how much you earn.
gross margin financial
"yielding a gross margin of approximately 23%"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
foreign exchange gains financial
"increased by approximately $21,000 ... due largely to foreign exchange gains"
Foreign exchange gains are increases in value a company records when currencies it holds or uses become stronger against its reporting currency, either from transactions (like sales or payments in another currency) or from revaluing foreign assets and liabilities. Like finding your foreign pocket change worth more after the exchange rate moves in your favor, these gains can raise reported profits and cash but can also add volatility, so investors watch them to separate one‑time currency effects from a company’s core performance.
forward-looking statements regulatory
"may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Product revenue - fire safety $336,000 from $0 in the prior-year quarter
Net loss $405,000 improved from $1,318,000 in the prior-year quarter
General and administrative expenses $497,000 down from $1,249,000 in the prior-year quarter
Guidance

The company estimates its current cash resources will fund planned expenditure into the first quarter of 2027.

FAQ

How did Bio Green Med Solution (BGMS) perform financially in Q2 2026?

Bio Green Med Solution reported a net loss of $405,000 for Q2 2026, improving from a $1,318,000 loss a year earlier. Revenue from fire safety products reached $336,000, reflecting the company’s strategic shift away from biopharmaceutical activities.

What were BGMS’s revenues and margins from its fire safety business in Q2 2026?

For Q2 2026, BGMS generated $336,000 in product revenue from fire safety equipment. Cost of sales was $257,000, resulting in a gross margin of approximately 23% on these sales as the new business line gains traction.

How has BGMS’s cost structure changed compared to Q2 2025?

General and administrative expenses declined to $497,000 in Q2 2026 from $1,249,000 in Q2 2025. The company attributes this decrease to one-time costs in 2025 related to changes of control and lower ongoing operating costs under current management.

What is BGMS’s cash position and runway as of June 30, 2026?

As of June 30, 2026, BGMS held $3.8 million in cash and cash equivalents, up from $3.5 million at December 31, 2025. Management estimates these resources will fund planned expenditure into the first quarter of 2027.

How did BGMS’s discontinued operations impact results in Q2 2026?

There was no activity from discontinued operations in Q2 2026. In Q2 2025, net loss from discontinued biopharmaceutical operations was $68,000, reflecting the company’s prior business before shifting focus to fire safety protection and distribution.

What does the Fitters Sdn. Bhd. acquisition mean for BGMS’s business model?

On September 12, 2025, BGMS acquired Fitters Sdn. Bhd., a Malaysia-based fire protection group. Since then, BGMS has focused on fire safety protection and distribution activities, moving away from its former biopharmaceutical operations and building revenue in this new segment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001130166 0001130166 2026-08-12 2026-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

August 12, 2026

Date of Report (date of earliest event reported)

 

 

Bio Green Med Solution, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-50626   91-1707622

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Level 10, Tower 11, Avenue 5, No. 8

Jalan Kerinchi, Kuala Lumpur, Malaysia 59200

(Address of principal executive offices) (Zip code)

 

(908) 955-0526

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   BGMS   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

and

 

Item 7.01. Regulation FD Disclosure.

 

The following information is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item 7.01, “Regulation FD Disclosure”, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

On August 12, 2026, Bio Green Med Solution Inc. issued a press release setting forth its second quarter 2026 results. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.   Exhibit
99.1   Press Release of Bio Green Med Solution, Inc. dated August 12, 2026
104   Cover Page Interactive Data File (embedded within the XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: August 13, 2026 Bio Green Med Solution, Inc.
     
  By: /s/ Datuk Dr. Doris Wong Sing Ee
  Name: Datuk Dr. Doris Wong Sing Ee
  Title: Chief Executive Officer and Executive Director

 

 

 

 

Exhibit 99.1

 

 

 

BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update

 

KUALA LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update.

 

Highlights of the second quarter ended June 30, 2026, or in some cases shortly thereafter, include:

 

In June, the Company, Future NRG Sdn. Bhd., a Malaysia private limited company (“FNRG”) and each of the shareholders of FNRG (the “Selling Shareholders”), entered into a Business Combination Agreement (the “BCA”), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the BCA, the Selling Shareholders will voluntarily exchange all of their ordinary shares in FNRG for shares of common stock, par value $0.001 of the Company (the “Exchange Shares”), resulting in FNRG becoming a wholly owned subsidiary of the Company (the “Exchange”). Subject to the terms and conditions of the BCA, at the closing of the Exchange: (a) each then-outstanding ordinary share of FNRG will be converted into the right to receive a number of Exchange Shares calculated in accordance with the BCA. Under the exchange ratio formula in the BCA, upon the closing of the Exchange, on a pro forma basis and based upon the number of Exchange Shares to be issued in the Exchange, the Selling Shareholders will own approximately more than 99% of the combined company and pre-Exchange Company stockholders will own approximately less than 1% of the combined company. The BCA contains certain termination rights of each of the Company and FNRG. In the event the Exchange is not closed by December 31, 2026, either party may terminate the BCA and the transactions contemplated thereunder.

 

In June, the Company entered into a Securities Purchase Agreement with certain foreign accredited investors, pursuant to which the investors agreed to purchase from the Company an aggregate of 1,103,338 shares of Common Stock, par value $0.001 of the Company at a purchase price of $0.72 per share for aggregate gross proceeds of $794,403, subject to the terms and conditions of the Purchase Agreement.

 

In July, the Board of Directors of the Company declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock, which cash dividend was paid on August 1, 2026, to holders of record as of the close of business on July 23, 2026;

 

 

 

 

Financial Highlights

 

As of June 30, 2026, cash and cash equivalents totaled $3.8 million, compared to $3.5 million as of December 31, 2025.

 

Net cash used in operating activities was $0.4 million for the three months ended June 30, 2026. The Company estimates that its current cash resources will fund planned expenditure into the first quarter of 2027.

 

Following the acquisition of Fitters Sdn. Bhd. on September 12, 2025, product revenue from sales and distribution of fire safety equipment was $336,000 for the three months ended June 30, 2026.

 

Cost of sales related to sales and distribution of fire safety equipment was $257,000 for the three months ended June 30, 2026, yielding a gross margin of approximately 23%

 

General and administrative expenses decreased by approximately $0.7 million from $1.2 million for the three months ended June 30, 2025 to $0.5 million for the three months ended June 30, 2026, due to several one-time costs associated with the two changes of control of the Company during 2025 and lower operating costs of the company under current management.

 

Total other income, net, for the three months ended June 30, 2026, increased by approximately $21,000 from $1,000 for the three months ended June 30, 2025 to $22,000 for the three months ended June 30, 2026, due largely to foreign exchange gains.

 

Income tax provision for the three months ended June 30, 2026, increased by approximately $7,000, from $2,000 for the three months ended June 30, 2025 to $9,000 for the three months ended June 30, 2026 and related to our fire safety business, acquired in September 2025.

 

Net loss from discontinued operations was $68,000 for the three months ended June 30, 2025 and is related to our former operations from biopharmaceutical activities. There was no activity from discontinued operations in the current period.

 

Net loss for the three months ended June 30, 2026, was $0.4 million, compared to $1.3 million for the same period in 2025.

 

About Bio Green Med Solution, Inc.

 

BGMS is a diversified company that was formerly engaged in the biopharmaceutical industry but as of September 2025 has shifted its operations to focus on provision of fire safety protection and distribution activities. Specifically, on September 12, 2025, the Company completed its acquisition of Fitters Sdn. Bhd., a Malaysia-based group specializing in fire protection products and services. Headquartered in Malaysia, the Company is now focused on advancing opportunities across these distinct sectors whilst maintaining its commitment to driving long-term value creation for shareholders. For additional information, please visit www.bgmsglobal.com.

 

Forward-looking Statements

 

Except for historical information, certain matters discussed in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve various assumptions, known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by words such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or other comparable words. Actual results, performance or outcomes may differ materially from those expressed or implied by these forward-looking statements and may not align with historical performance and events due to a number of factors, including those discussed in the sections of our annual report on Form 10-K entitled “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors,” and those discussed in our Form 10-Q quarterly reports filed after such annual report. BGMS’s SEC filings are readily obtainable at no charge at www.sec.gov, as well as on its own investor relations website at https://investor.bgmsglobal.com/sec-filings. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and caution should be exercised against placing undue reliance upon such statements, which are based only on information currently available to us and speak only as of the date hereof. We are under no duty to update publicly any of the forward-looking statements after the date of this earnings press release, whether as a result of new information, future events or otherwise, except as required by law.

 

SOURCE:

Bio Green Med Solution, Inc.

info@bgmsglobal.com

 

 

 

 

BIO GREEN MED SOLUTION, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (LOSS)

(In $000s, except share and per share amounts)

 

   Three Months Ended 
   June 30, 
   2026   2025 
         
Revenues:          
Product revenue - fire safety  $336   $- 
Revenues  $336   $- 
           
Operating expenses:          
Cost of sales   257    - 
General and administrative   497    1,249 
Total operating expenses   754    1,249 
Operating loss   (418)   (1,249)
Other income (expense):          
Foreign exchange gains (losses)   (18)   (3)
Interest income   9    2 
Other income, net   31    2 
Total other income, net   22    1 
Loss from continuing operations before taxes   (396)   (1,248)
Income tax provision   (9)   (2)
Net loss from continuing operations   (405)   (1,250)
Discontinued operations:          
Operating losses from discontinued operations   -    (68)
Net income from discontinued operations   -    (68)
Net loss   (405)   (1,318)
Dividend on convertible exchangeable preferred shares   (20)   (20)
Net loss applicable to common shareholders  $(425)  $(1,338)
Basic and diluted earnings per common share:          
Net loss per share, continuing operations – basic and diluted (common shareholders)  $(0.08)  $(0.93)
Net income per share, discontinued operations – basic and diluted (common shareholders)  $-   $(0.05)
           
 Weighted average common shares outstanding   5,598,701    1,360,626 

 

 

 

 

BIO GREEN MED SOLUTION, INC.

CONSOLIDATED BALANCE SHEET

(In $000s, except share, per share, and liquidation preference amounts)

 

   June 30, 2026   December 31, 2025 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $3,790   $3,505 
Inventory   972    1,384 
Accounts receivable   1,074    1,257 
Prepaid expenses and other current assets   133    110 
Total current assets   5,969    6,256 
           
Property and equipment, net
Property and equipment, net
   136    137 
Right-of-use lease asset   7    12 
Goodwill   1,570    1,570 
Property and equipment, net
Non-current deposits
   172    210 
Total assets  $7,854   $8,185 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $189   $617 
Accrued and other current liabilities   503    715 
Total current liabilities   692    1,332 
Lease liability   -    2 
Other liabilities   2    9 
Total liabilities   694    1,343 
           
Stockholders’ equity   7,160    6,842 
Total liabilities and stockholders’ equity  $7,854   $8,185 

 

 

 

Filing Exhibits & Attachments

5 documents